Skip to main content
. 2023 Oct 6;10:1288521. doi: 10.3389/fmed.2023.1288521

Table 2.

Lesion characteristics by analysis population.

FA (N) ITT (N) PP (N)
Total 611 587 585
No. of Lesions assessed (count = number of participants) 1 532 505 504
2 38 38 38
3 2 2 2
Lesion size (mm) Mean 9 8.6 8.6
SD 4.9 3.5 3.5
Median 8 8 8
Minimum 0.8 0.8 0.8
Maximum 64 20 20
Lesion location Face and scalp 281 271 271
Neck 21 21 21
Anterior chest and abdomen 56 55 54
Posterior chest and back 90 85 85
Arms, excluding palms 80 79 79
Palms 1 1 1
Legs, excluding soles 80 73 72
Soles 2 2 2
Patient level of concern Not concerned 144 138 138
A little concerned 307 299 299
Very concerned 135 126 124
Unknown 25 24 24
Experience of reviewing clinician Foundation doctor 55 54 54
Specialty registrar 20 19 18
Consultant 455 440 439
Other/GPwSI 81 74 74
Missing 0 0 0
Lesion change None 110 104 104
Changed color 20 20 20
Symptomatic 179 172 172
Grown a bit 112 109 108
New lesion 160 154 154
Grown a lot 30 28 27
Clinician assessment of likelihood of skin cancer Unlikely 224 216 215
Equivocal 61 59 59
Likely 211 203 202
Highly likely 115 109 109
Biopsy taken Lesion not referred for biopsy 167 163 162
Further clinical review determined no biopsy needed 7 7 7
Biopsy taken 418 398 397
Patient refused biopsy 5 5 5
Other 14 14 14

FA, Full Analysis; ITT, Intention-to-Treat; PP, Per Protocol; SD, Standard Deviation; GPwSI, General Practitioner with Special Interest. Number of lesions equates to number of lesion records created in the study database, the lesion count is based on clinician provided information on the number of lesions they assessed for each patient.